5 Value Stocks In The Healthcare Sector
5 Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks
價值股背後的意義
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
傳統上，與同行業公司的股票價格相比，價值股票的價格較低。這表明該公司的估值可能被低估了，因爲投資者對此類公司的興趣不大。最常用的價值檢查方法是市盈倍數或市盈率。低市盈倍數很好地表明股票被低估了。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被認爲是醫療保健領域值得注意的價值股票：
- Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.76
- Viatris (NASDAQ:VTRS) - P/E: 8.96
- InMode (NASDAQ:INMD) - P/E: 9.28
- Solid Biosciences (NASDAQ:SLDB) - P/E: 0.14
- Exicure (NASDAQ:XCUR) - P/E: 0.34
- 基奧拉制藥（納斯達克股票代碼：KPRX）——市盈率：0.76
- Viatris（納斯達克股票代碼：VTRS）——市盈率：8.96
- InMode（納斯達克股票代碼：INMD）——市盈率：9.28
- Solid Biosciences（納斯達克股票代碼：SLDB）——市盈率：0.14
- Exicure（納斯達克股票代碼：XCUR）——市盈率：0.34
Kiora Pharmaceuticals has reported Q3 earnings per share at $-0.89, which has decreased by 12.66% compared to Q2, which was -0.79. This quarter, Viatris experienced an increase in earnings per share, which was $0.75 in Q2 and is now $0.79. Most recently, the company reported a dividend yield of 5.18%, which has increased by 0.59% from last quarter's yield of 4.59%.
Kiora Pharmicals公佈的第三季度每股收益爲-0.89美元，與第二季度的-0.79美元相比下降了12.66％。本季度，Viatris的每股收益有所增加，第二季度爲0.75美元，目前爲0.79美元。最近，該公司公佈的股息收益率爲5.18％，較上個季度的4.59％的收益率增長了0.59％。
Most recently, InMode reported earnings per share at $0.71, whereas in Q3 earnings per share sat at $0.61. This quarter, Solid Biosciences experienced an increase in earnings per share, which was $-1.25 in Q2 and is now $-1.05. Exicure saw an increase in earnings per share from -0.7 in Q1 to $-0.68 now.
最近，InMode公佈的每股收益爲0.71美元，而第三季度的每股收益爲0.61美元。本季度，Solid Biosciences的每股收益有所增加，第二季度爲-1.25美元，目前爲-1.05美元。Exicure的每股收益從第一季度的-0.7美元增長到現在的-0.68美元。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
這5只價值股是Benzinga Insights根據量化分析選擇的。儘管這種有條理的判斷過程並不意味着做出最終決定，但我們的技術可以讓投資者對該行業有更多的認識。
譯文內容由第三人軟體翻譯。